oxprenolol has been researched along with Subarachnoid Hemorrhage in 2 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, HL | 1 |
| Campbell, BC | 1 |
| Morgan, I | 1 |
| Cruickshank, JM | 1 |
| Neil-Dwyer, G | 1 |
2 other studies available for oxprenolol and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Beta-blockade in subarachnoid haemorrhage.
Topics: Arrhythmias, Cardiac; Humans; Male; Middle Aged; Oxprenolol; Subarachnoid Hemorrhage | 1978 |
Beta-blocker brain concentrations in man.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Brain Chemistry; Cats; Humans; Lipid Metabolism; Met | 1985 |